logo BDSP

Base documentaire

  1. Mortality among HIV-infected intravenous drug addicts in Stockholm in relation to methadone treatment.

    Article - En anglais

    The aim of the study was to estimate the mortality rate and evaluate the causes of death in all diagnosed HIV-positive IDUs in the Stockholm area, 1986-90, and to compare the risk of death of those who received methadone treatment with that of those never admitted ot or discharged from the rpogramme.

    Data were collected from the Swedish National Bacteriological Laboratory, the Methadone Maintenance Programme and the Department of Forensic Medicine, as well as from hospitals in the Stockholm region.

    In Sweden 90% of all IDUs are HIV-tested.

    Most deceased IDUs are examined forensically.

    This examination always includes HIV-testing.

    During the observation period, 472 HIV-infected IDUs were reported from the Stockholm area.

    Of these addicts 135 participated in the methadone maintenance programme for a shorter or longer time during the study period.

    Most of them had received the HIV-diagnosis more than 1 year before first entering the programme.

    Sixty-nine subjects died during the observation period.

    A majority, 52 persons, died from violence or poisoning.

    Seventeen died from somatic complications of drug abuse.

    When all causes of death are compared the relative risk was 0.8. Those patients discharged from the programme have a higher mortality rate than those who never participated.

    It is concluded that the programme probably contributes to a higher survival rate than for patients outside the MMTP by offering them social support, medical care and control of their drug abuse.

    Mots-clés Pascal : Toxicomanie, Voie intraveineuse, SIDA, Virose, Infection, Immunopathologie, Immunodéficit, Méthadone, Analgésique narcotique, Mortalité, Enquête, Suède, Europe, Etiologie, Homme

    Mots-clés Pascal anglais : Drug addiction, Intravenous administration, AIDS, Viral disease, Infection, Immunopathology, Immune deficiency, Narcotic analgesic, Mortality, Inquiry, Sweden, Europe, Etiology, Human

    Logo du centre Notice produite par :
    Inist-CNRS - Institut de l'Information Scientifique et Technique

    Cote : 95-0333818

    Code Inist : 002B18C05A. Création : 01/03/1996.